These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18192886)

  • 1. Impaired E-cadherin expression and glutamine synthetase overexpression in solid pseudopapillary neoplasm of the pancreas.
    Audard V; Cavard C; Richa H; Infante M; Couvelard A; Sauvanet A; Terris B; Paye F; Flejou JF
    Pancreas; 2008 Jan; 36(1):80-3. PubMed ID: 18192886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and significance of adenomatous polyposis coli, beta-catenin, E-cadherin and cyclin D1 in esophageal squamous cell carcinoma assessed by tissue microarray.
    Peng H; Zhong XY; Liu KP; Li SM
    Ai Zheng; 2009 Jan; 28(1):38-41. PubMed ID: 19448414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
    Chetty R; Serra S; Salahshor S; Alsaad K; Shih W; Blaszyk H; Woodgett JR; Tsao MS
    Hum Pathol; 2006 Feb; 37(2):212-7. PubMed ID: 16426922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear expression of E-cadherin in solid pseudopapillary tumors of the pancreas.
    Serra S; Salahshor S; Fagih M; Niakosari F; Radhi JM; Chetty R
    JOP; 2007 May; 8(3):296-303. PubMed ID: 17495358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].
    Yang JF; Chen SL; Liu ZH; Zhang Y
    Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
    Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
    J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas.
    El-Bahrawy MA; Rowan A; Horncastle D; Tomlinson I; Theis BA; Russell RC; Stamp G
    Am J Surg Pathol; 2008 Jan; 32(1):1-7. PubMed ID: 18162763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
    Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
    Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ; Jang SJ; Yu E
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis.
    Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H
    Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Wnt pathway gene expression and E-cadherin truncation in sporadic colorectal cancers with and without microsatellite instability.
    Ortega P; Morán A; de Juan C; Frías C; Hernández S; López-Asenjo JA; Sánchez-Pernaute A; Torres A; Iniesta P; Benito M
    Clin Cancer Res; 2008 Feb; 14(4):995-1001. PubMed ID: 18281531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC; Lee MS
    Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
    Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
    Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
    Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
    World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor progression induced by the loss of E-cadherin independent of beta-catenin/Tcf-mediated Wnt signaling.
    Herzig M; Savarese F; Novatchkova M; Semb H; Christofori G
    Oncogene; 2007 Apr; 26(16):2290-8. PubMed ID: 17043652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
    Audard V; Grimber G; Elie C; Radenen B; Audebourg A; Letourneur F; Soubrane O; Vacher-Lavenu MC; Perret C; Cavard C; Terris B
    J Pathol; 2007 Jul; 212(3):345-52. PubMed ID: 17487939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
    Demirkan NC; Bir F; Erdem O; Düzcan E
    J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.